Cargando…
A possible explanation for the peripheral selectivity of a novel non-steroidal pure antiandrogen, Casodex (ICI 176,334).
The in vivo antiandrogenicity of Casodex has been confirmed and characterised. Androgen receptor (AR) binding assays of rat ventral prostate gland cytosols revealed a relative binding affinity (RBA) for the AR of 0.267 and a k1 of 1.25 x 10(-7) M for Casodex. In addition, the peripheral selectivity...
Autores principales: | Freeman, S. N., Mainwaring, W. I., Furr, B. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247300/ https://www.ncbi.nlm.nih.gov/pubmed/2803943 |
Ejemplares similares
-
Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model
por: Rothermund, Christy A, et al.
Publicado: (2005) -
Possible Aripiprazole-Induced Hypothermia: An “Icy” Side Effect?
por: Bhandari, Sambhawana, et al.
Publicado: (2021) -
Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review
por: Kunath, Frank, et al.
Publicado: (2012) -
Health Tract No. 334: Boxing the Ears
Publicado: (1868) -
ICIS05 CONFERENCE
por: Lau, C, et al.
Publicado: (02/1)